- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Amicus Therapeutics (FOLD)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 184.73 mm | 184.73 mm | 184.73 mm | 184.73 mm | 184.73 mm | 184.73 mm |
Cash burn (monthly) | 10.66 mm | 2.34 mm | 6.02 mm | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 37.49 mm | 8.22 mm | 21.15 mm | n/a | n/a | n/a |
Cash remaining | 147.25 mm | 176.51 mm | 163.58 mm | n/a | n/a | n/a |
Runway (months of cash) | 13.8 | 75.5 | 27.2 | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 284 |
Opened positions | 41 |
Closed positions | 43 |
Increased positions | 106 |
Reduced positions | 101 |
13F shares | Current |
---|---|
Total value | 2.83 tn |
Total shares | 304.94 mm |
Total puts | 514.70 k |
Total calls | 466.90 k |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 29.26 mm | $275.62 bn |
Wellington Management | 28.46 mm | $268.11 bn |
BlackRock | 27.91 mm | $262.89 bn |
Perceptive Advisors | 24.25 mm | $228.40 bn |
Avoro Capital Advisors | 23.18 mm | $218.31 bn |
William Blair Investment Management | 15.60 mm | $146.93 bn |
STT State Street | 10.36 mm | $97.60 bn |
Citadel Advisors | 8.24 mm | $77.62 bn |
Palo Alto Investors | 7.66 mm | $72.18 bn |
JPM JPMorgan Chase & Co. | 7.21 mm | $67.96 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jun 25 | Whitman Burke W | Common Stock | Grant | Acquire A | No | No | 0 | 20,414 | 0.00 | 118,598 |
5 Jun 25 | Whitman Burke W | Stock Options Common Stock | Grant | Acquire A | No | No | 5.96 | 74,872 | 446.24 k | 74,872 |
5 Jun 25 | Wheeler Craig A | Common Stock | Grant | Acquire A | No | No | 0 | 20,414 | 0.00 | 84,631 |
5 Jun 25 | Wheeler Craig A | Stock Options Common Stock | Grant | Acquire A | No | No | 5.96 | 74,872 | 446.24 k | 74,872 |
5 Jun 25 | Bleil Lynn Dorsey | Common Stock | Grant | Acquire A | No | No | 0 | 20,414 | 0.00 | 113,941 |
5 Jun 25 | Bleil Lynn Dorsey | Stock Options Common Stock | Grant | Acquire A | No | No | 5.96 | 74,872 | 446.24 k | 74,872 |
5 Jun 25 | Roberts Eiry | Common Stock | Grant | Acquire A | No | No | 0 | 20,414 | 0.00 | 76,275 |
5 Jun 25 | Roberts Eiry | Stock Options Common Stock | Grant | Acquire A | No | No | 5.96 | 74,872 | 446.24 k | 74,872 |
5 Jun 25 | Kelly Michael Aaron | Common Stock | Grant | Acquire A | No | No | 0 | 20,414 | 0.00 | 72,468 |
5 Jun 25 | Kelly Michael Aaron | Stock Options Common Stock | Grant | Acquire A | No | No | 5.96 | 74,872 | 446.24 k | 74,872 |